Evotec SE (EVO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.00
-4.46%
Mkt Cap $1.08B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+133.3%
Consensus $7.00 vs current $3.00
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.00
-4.46%
Mkt Cap $1.08B
No recent rating data.
Price Target (4 analysts)
$7.00
Range $7.00 – $7.00
+133.3%
Consensus $7.00 vs current $3.00